Physician profile
Mona A Ayoub
NPI 1114199551
$276.60
in general payments reported to CMS, 2019-2025
11 companies · $123 in 2025
The $123 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.35 · 2020: $15.00 · 2021: $11.81 · 2022: $27.95 · 2024: $71.87 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $50.14 | 2022-2025 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $50.04 | 2024-2025 | |
| Genentech USA, INC. | $30.00 | 2019-2020 | |
| Cranial Technologies, INC | $28.05 | 2019-2025 | Doc Band |
| Krystal Biotech INC | $24.29 | 2024 | Vyjuvek |
| Sanofi Pasteur INC. | $18.74 | 2024 | |
| Alk-Abello, INC | $17.95 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $17.42 | 2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Aytu Biopharma, INC. | $14.53 | 2022 | |
| Neurelis, INC. | $13.63 | 2024 | Valtoco |
| Neos Therapeutics, LP | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Ayoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.